Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)

Approximately 5% of patients with sarcoidosis have clinically manifest cardiac involvement. Clinical features of Cardiac Sarcoidosis are dependent on the location, extent, and activity of the disease. First line therapy is usually with prednisone and this is recommended based on clinician experience...

Full description

Saved in:

Bibliographic Details
Published in:	The American heart journal Vol. 220; pp. 246 - 252
Main Authors:	Birnie, David, Beanlands, Rob S.B., Nery, Pablo, Aaron, Shawn D., Culver, Daniel A., DeKemp, Robert A., Gula, Lorne, Ha, Andrew, Healey, Jeffery S., Inoue, Yuko, Judson, Mark A., Juneau, Daniel, Kusano, Kengo, Quinn, Russell, Rivard, Lena, Toma, Mustafa, Varnava, Amanda, Wells, George, Wickremasinghe, Melissa, Kron, Jordana
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01.02.2020 Elsevier Limited
Subjects:	Arrhythmia Biomarkers Biomedical materials Cardiomyopathies - complications Cardiomyopathies - drug therapy Clinical trials Conduction Corticosteroids Diabetes mellitus Drug Administration Schedule Drug Therapy, Combination Equivalence Trials as Topic Fibrosis Glucocorticoids - administration & dosage Glucocorticoids - adverse effects Health risks Heart Humans Hypertension Immunomodulators Methotrexate Methotrexate - administration & dosage Multicenter Studies as Topic Osteoporosis Patients Perfusion Physicians Prednisone Prednisone - administration & dosage Prednisone - adverse effects Prospective Studies Quality of Life Randomization Randomized Controlled Trials as Topic Research Design Sarcoidosis Sarcoidosis - complications Sarcoidosis - drug therapy Side effects Steroid hormones Steroids Ventricle United Kingdom > UK Canada United States > US
ISSN:	0002-8703, 1097-6744, 1097-6744
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!